Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

Per Soelberg Sorensen^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

7 Citationer (Scopus)

Adgang til dokumentet

@article{6df5658212c149a79a051657a1714009,

title = "Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO",

author = "{Soelberg Sorensen}, Per",

year = "2016",

doi = "10.1177/1352458516644341",

language = "English",

volume = "22",

pages = "1260--1263",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "10",

}

TY - JOUR

T1 - Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

AU - Soelberg Sorensen, Per

PY - 2016

Y1 - 2016

U2 - 10.1177/1352458516644341

DO - 10.1177/1352458516644341

M3 - Journal article

C2 - 27444559

AN - SCOPUS:84986569338

SN - 1352-4585

VL - 22

SP - 1260

EP - 1263

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 10

ER -